Redifferentiation-enabled TSHRCART cells overcome antigen loss in aggressive thyroid cancers.

Manriquez-Roman C, Siegler EL, Gleba JJ, Huynh TN, DeFranco GE, Demirer AA, Pawlush ML, Redig M, Klinge SM, Mai LK, Miller JL, Miller EE, Kimball BL, Tapper EE, Sakemura RL, Stewart CM, Can I, Sirpilla OL, Feigin JM, Yun K, Gutierrez-Ruiz OL, Xia H, Hefazi M, Schick KJ, Ogbodo EJ, Olivier G, Qiu Y, Smallridge RC, Zubair A, Tun HW, Copland JA, Kenderian SS

Open source

DOI: 10.1186/s12943-026-02744-0
Published: 2026 Jul 31
Container: Molecular cancer
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12943-026-02744-0,
  title = {Redifferentiation-enabled TSHRCART cells overcome antigen loss in aggressive thyroid cancers.},
  author = {Manriquez-Roman C and Siegler EL and Gleba JJ and Huynh TN and DeFranco GE and Demirer AA and Pawlush ML and Redig M and Klinge SM and Mai LK and Miller JL and Miller EE and Kimball BL and Tapper EE and Sakemura RL and Stewart CM and Can I and Sirpilla OL and Feigin JM and Yun K and Gutierrez-Ruiz OL and Xia H and Hefazi M and Schick KJ and Ogbodo EJ and Olivier G and Qiu Y and Smallridge RC and Zubair A and Tun HW and Copland JA and Kenderian SS},
  year = {2026},
  journal = {Molecular cancer},
  doi = {10.1186/s12943-026-02744-0},
  url = {https://doi.org/10.1186/s12943-026-02744-0}
}

RIS

TY  - JOUR
TI  - Redifferentiation-enabled TSHRCART cells overcome antigen loss in aggressive thyroid cancers.
AU  - Manriquez-Roman C
AU  - Siegler EL
AU  - Gleba JJ
AU  - Huynh TN
AU  - DeFranco GE
AU  - Demirer AA
AU  - Pawlush ML
AU  - Redig M
AU  - Klinge SM
AU  - Mai LK
AU  - Miller JL
AU  - Miller EE
AU  - Kimball BL
AU  - Tapper EE
AU  - Sakemura RL
AU  - Stewart CM
AU  - Can I
AU  - Sirpilla OL
AU  - Feigin JM
AU  - Yun K
AU  - Gutierrez-Ruiz OL
AU  - Xia H
AU  - Hefazi M
AU  - Schick KJ
AU  - Ogbodo EJ
AU  - Olivier G
AU  - Qiu Y
AU  - Smallridge RC
AU  - Zubair A
AU  - Tun HW
AU  - Copland JA
AU  - Kenderian SS
PY  - 2026
JO  - Molecular cancer
DO  - 10.1186/s12943-026-02744-0
UR  - https://doi.org/10.1186/s12943-026-02744-0
ER  -

APA

C, M., EL, S., JJ, G., TN, H., GE, D., AA, D., ML, P., M, R., SM, K., LK, M., JL, M., EE, M., BL, K., EE, T., RL, S., CM, S., I, C., OL, S., JM, F., K, Y., OL, G., H, X., M, H., KJ, S., EJ, O., G, O., Y, Q., RC, S., A, Z., HW, T., JA, C., & SS, K. (2026). Redifferentiation-enabled TSHRCART cells overcome antigen loss in aggressive thyroid cancers.. Molecular cancer. https://doi.org/10.1186/s12943-026-02744-0

Source records

pubmed · retrieved 2026-09-26T01:21:23.287Z
europe-pmc · retrieved 2026-09-26T01:21:23.291Z
doaj · retrieved 2026-09-26T01:21:23.327Z